Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

NCT05914116

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +52 more
Locations
  • Research Site 111 Tucson, Arizona, United States
  • Research Site 125 Los Angeles, California, United States
  • Research Site 133 Los Angeles, California, United States
  • Research Site 103 Los Angeles, California, United States
View all 107 locations
View Trial Details
Recruiting

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

NCT06088381

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +16 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
  • Central Maryland Radiation Oncology Columbia, Maryland, United States
View Trial Details
Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

NCT00898638

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +22 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

NCT06699212

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • City of Hope Duarte, California, United States
  • University of Miami Miami, Florida, United States
  • Tampa General Hospital Tampa, Florida, United States
  • University of Kentucky Medical Center Lexington, Kentucky, United States
View all 22 locations
View Trial Details
Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT04370587

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions